# |
Company Name
|
Industry Name
|
Latest Price
(Rs.) |
Price Change
Rs (%) |
Market Cap
|
Net Sales
(Rs. Cr.) |
Latest EPS
(Rs.) |
Net Profit
Margin % |
Latest
P/E |
Latest
P/BV |
---|---|---|---|---|---|---|---|---|---|---|
Zydus Lifesciences | Pharmaceuticals& Drugs | 969.7 |
-20.9 (-2.11%) |
Mid Cap | 17,237 | 29.4 | 10.4 | 33.7 | 5.2 | |
Lupin | Pharmaceuticals& Drugs | 1,566 |
-47.4 (-2.94%) |
Mid Cap | 16,642 | 39.3 | 2.27 | 41 | 5.3 | |
Aurobindo Pharma | Pharmaceuticals& Drugs | 990.6 |
-26.9 (-2.64%) |
Mid Cap | 12,792 | 33.6 | 9.24 | 30.3 | 3.1 | |
Alkem Laboratories | Pharmaceuticals& Drugs | 4,874.7 |
-104.2 (-2.09%) |
Mid Cap | 9,055 | 140.3 | 12.31 | 35.5 | 5.6 | |
Ipca Laboratories | Pharmaceuticals& Drugs | 1,140 |
-25.65 (-2.2%) |
Mid Cap | 5,775 | 21.7 | 8.82 | 53.7 | 4.7 | |
Abbott India | Pharmaceuticals& Drugs | 28,250.9 |
-363.3 (-1.27%) |
Mid Cap | 5,349 | 539.1 | 17.8 | 53.1 | 17.8 | |
Max Healthcare Inst | Hospital &HealthcareServices | 730.6 |
-0.1 (-0.01%) |
Mid Cap | 4,563 | 10.9 | 24.15 | 67.2 | 8.7 | |
Gland Pharma | Pharmaceuticals& Drugs | 1,786.3 |
-2.65 (-0.15%) |
Mid Cap | 3,617 | 48.6 | 21.44 | 36.8 | 3.4 | |
Glaxosmithkline Phar | Pharmaceuticals& Drugs | 1,974.7 |
-3.15 (-0.16%) |
Mid Cap | 3,252 | 31.2 | 18.01 | 63.4 | 21.1 | |
Biocon | Pharmaceuticals& Drugs | 245.5 |
-5 (-2%) |
Mid Cap | 1,993 | 16 | 41.18 | 15.7 | 2.8 | |
Global Health | Hospital &HealthcareServices | 1,211.9 |
26.5 (2.24%) |
Mid Cap | 1,959 | 13 | 13.52 | 91 | 11.6 | |
Fortis Healthcare | Hospital &HealthcareServices | 399.4 |
-1.55 (-0.39%) |
Mid Cap | 1,053 | 1.8 | 9.18 | 227.3 | 3.4 |